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Abstract
Background: Cardio-Renal Syndromes were first classified in 2008 and divided into five subtypes. The type 1
Cardio-Renal Syndrome (CRS) is characterized by acute decompensation of heart failure leading to acute kidney
injury (AKI). Bradyarrhythmia was not mentioned in the classification as a cause for low cardiac output (CO) in type
1 CRS. Besides, CRS was not previously associated with central nervous system (CNS) injury despite the fact that
cardiac, renal and neurological diseases can coexist.
Case presentation: We report the case of a 93-year old diabetic man who presented for obnubilation. He had a
slow atrial fibrillation, was not hypotensive and was not taking any beta-blocker. He developed, simultaneously,
during his hospitalization, severe bradycardia (<35 beats per minute), oligoanuria and further neurological
deterioration without profound hypotension. An ECG revealed a complete atrioventricular (AV) block and all his
symptoms were completely reversed after pacemaker insertion. His creatinine decreased progressively afterwards
and at discharge, he was conscious, alert and well oriented.
Conclusion: Our case highlights the importance of an early recognition of low cardiac output secondary to
severe bradyarrhythmia and its concurrent repercussion on the kidney and the brain. This association of the CRS
with CNS injury-that we called “Cardio-Renal-Cerebral Syndrome”–was successfully treated with permanent
pacemaker implantation.
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Background
The Cardio-Renal Syndrome (CRS) is an entity that ne-
phrologists are often faced to. It has been defined by
Ronco et al. as a pathophysiologic disorder of the heart
and kidneys whereby acute or chronic dysfunction of
one organ may induce acute or chronic dysfunction of
the other [1]. The Cardio-Renal Syndromes are subdi-
vided into five different subtypes in order to allow physi-
cians to better understand the situation and offer
adequate treatment [2]. The type 1 CRS is characterized
by acute worsening of heart failure leading to acute kid-
ney injury (AKI). It is considered to be the most com-
mon type of CRS and is present in approximately 25 %
of patients admitted with acute decompensated heart
failure (ADHF) [3]. Bradyarrhythmia was not mentioned
in the classification as a cause for low cardiac output
(CO) in type 1 CRS. As well as the association of type 1
CRS with central nervous system (CNS) injury has not
been previously described.
We report here a case of type 1 CRS with ADHF sec-
ondary to complete atrioventricular (AV) block con-
comitant with neurological deterioration.
Case presentation
A 93-year old man was brought to the emergency room
for recent neurological deterioration. His past medical
history was relevant for hypertension, diabetes mellitus,
dyslipidemia, coronary artery disease, chronic atrial fib-
rillation and mild memory loss. He had no history of
kidney disease. His chronic medication included
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clopidogrel, acenocoumarol, amlodipine, atorvastatin,
molsidomine and furosemide; he was on levofloxacin
since two weeks for pneumonia. On admission, the
patient’s physical examination revealed obnubilation with
episodes of agitation, a blood pressure of 160/80 mmHg,
an irregular heart rate of 50 beats per minute (bpm), jugu-
lar venous distention, decreased bilateral basal breath
sounds, no fever and no leg edema. He was not obese.
Initial abnormal serum laboratory results included: white
blood cell (WBC) count of 12630/mm3 (84 % neutro-
phils), international normalized ratio (INR) of 4.5, cre-
atinine of 2.3 mg/dL (203 μmol/L), blood urea nitrogen
(BUN) of 80 mg/dL (28.5 mmol/L), albumin of 3.2 g/dL
(32 g/L), phosphorus of 5.9 mg/dL (1.96 mmol/L) and
gamma glutamyl transferase of 275 UI/L. He had a positive
troponin I of 0.27 ng/mL but normal CPK and CPK-MB.
C-reactive protein was 19 mg/L. He had no electrolytes’
disturbance (potassium 4.9 mmol/L, sodium 144 mmol/L,
chloride 110 mmol/L, bicarbonate 23 mmol/L), no
hypocalcemia (corrected calcium 8.9 mg/dL) nor
anemia (hemoglobin 13.4 g/dL, hematocrit 42 %). Urin-
alysis showed 3+ protein.
Further investigations revealed left lung basal consoli-
dation with bilateral effusion on chest X-ray. The arterial
blood gas (ABG) showed: pH 7.27, PaO2 91 mmHg,
PaCO2 52 mmHg, HCO3ˉ 23 mmol/L. Electrocardio-
gram (ECG) on admission showed a slow atrial fibrillation
of 55 bpm (Fig. 1). Brain computed tomography (CT)
scanning ruled out possible ischemic or hemorrhagic
stroke.
The patient was admitted to the intensive care unit
(ICU). An echocardiography showed a left ventricular
ejection fraction (LVEF) of 40 %, ventricular hyper-
trophy, pulmonary arterial pressure of 40 mmHg, dilated
right ventricle and slightly enlarged left atrium. Renal
ultrasound was normal.
Empiric antibiotics were started combining ceftriaxone
and levofloxacin; fluconazole was added at day 2 after
sputum cultures grew Candida albicans. Urine culture
was sterile.
During cardiac monitoring in the ICU, episodes of ex-
treme bradycardia were noticed as low as 32 bpm with
maintained systolic blood pressure at 100–120 mmHg
and very low diastolic blood pressure of 30–40 mmHg.
On day 3, the patient became unconscious and de-
veloped severe respiratory acidosis with ABG showing:
pH 7.16, PaCO2 64 mmHg, PaO2 75 mmHg, HCO3ˉ
22 mmol/L and he was intubated. He concomitantly
became oligoanuric and serum creatinine started to
increase. A spot urine test revealed a sodium (Na) of
22 mmol/L and potassium (K) of 34 mmol/L with a ra-
tio Na/K <1. He received sodium bicarbonate when-
ever his bicarbonate level was less than 22.
Complete AV block was then identified on ECG. A
temporary pacemaker was implanted on day 5 and the
patient was extubated. Serum creatinine decreased and
urine output improved considerably. Table 1 illustrates
the heart rate (HR), urine output, systolic and diastolic
blood pressure values, serum creatinine and potassium
variations before and after the pacemaker insertion.
The patient finally got a permanent single chamber
pacemaker VVIR and improved considerably his con-
sciousness and renal function. At discharge he had a
serum creatinine of 1.6 mg/dL and he was conscious,
alert and well oriented.
Discussion
Depending on every patient’s situation, Ronco et al. de-
scribed four subtypes of type 1 CRS: 1) de novo cardiac
injury leads to de novo kidney injury; 2) de novo cardiac
injury leads to acute-on-chronic kidney injury; 3) acute-
on-chronic cardiac decompensation leads to de novo
kidney injury; and 4) acute-on-chronic cardiac decom-
pensation leads to acute-on-chronic kidney injury [4].
Our patient can be classified in the fourth category of
type 1 CRS. The severe bradycardia decompensated his
chronic heart failure and led to AKI on the top of a
probable chronic diabetic nephropathy. AKI in our pa-
tient was diagnosed using the definition of RIFLE, AKIN
and KDIGO classifications as an increase in serum
Fig. 1 ECG on admission showing slow atrial fibrillation
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creatinine to more than 1.5-fold over baseline [5]. The
factors usually implicated in the pathogenesis of AKI in
type 1 CRS are multiple and complex [4]. But the main
classical pathophysiological mechanism to consider first
in any type 1 CRS remains the hemodynamic factor: an
inadequate renal perfusion secondary to an acute low
CO or acute heart failure (HF). In the classification of
type 1 CRS, the authors did not emphasize on the bra-
dyarrhythmia as a possible aetiology for low CO [1].
Patients with ADHF and type 1 CRS have usually poor
outcomes especially when accompanied by severe
hypotension that is not reversible [6]. But low CO, that
is generally believed to occur secondary to a decreased
LVEF, results sometimes from bradyarrhythmia [7, 8].
Patients with HF due to left ventricular (LV) pump fail-
ure and those with HF due to bradyarrhythmia have
similar reductions in CO. However the stroke volume is
reduced in patients with LV pump failure whereas it is
increased in bradyarhythmia [7]. This increase in stroke
volume is mandatory to ensure the hemodynamic stabil-
ity of the patient with bradycardia. The inability to in-
crease stroke volume due to decreased myocardial
reserve secondary to a pre-existing heart failure decom-
pensates the patient [8]. The fact that our patient had a
previous low LVEF contributed to his hemodynamic in-
stability once the severe bradycardia occurred. And the
low urinary sodium suggested the presence of a low CO.
We found one case in the literature that combined re-
petitive oliguric AKI with intermittent third-degree AV
block secondary to propranolol [9]. The cause of brady-
cardia and complete AV block in our patient was not
completely clarified. No medications, no hyperkalemia
and no extrinsic factors incriminated with bradycardia
were found [10]. One plausible hypothesis that could ex-
plain our patient’s signs and symptoms and sequential
events is the presence of a sick sinus syndrome. It is well
known that, at least, 50 % of patients with sick sinus
syndrome develop alternating bradycardia and tachy-
cardia with atrial fibrillation as the tachyarrhythmia.
Sick sinus syndrome is more frequent in the elderly
and lead to end-organ hypoperfusion mainly cerebral
hypoperfusion. And in 50 % of the cases AV block com-
plicates the sick sinus syndrome [10, 11]. The diagnosis
is challenging in most of the cases. In our case, the ab-
sence of documented sinus bradycardia make the diag-
nosis of sick sinus syndrome more difficult to establish.
But whether the complete AV block was superimposed
on a sick sinus syndrome or not, the only therapy to be
considered in our symptomatic severely bradycardic pa-
tient was pacemaker placement [12]. Pacemaker ther-
apy is indicated only to relieve symptoms in sick sinus
syndrome and improve the patient’s quality of life but
unfortunately has not been shown to affect survival
rates [11]. The successful reversal of AKI and obnubil-
ation after cardiac pacing confirms the fact that
complete AV block was the cause behind all our
patient’s symptoms.
Concerning the association of low CO with cerebral
hypoperfusion, there have been several reports in the
literature. First, it is known that chronic heart failure
is associated with abnormal brain changes, including
cognitive impairment, structural changes, and demen-
tia [13, 14] and may have contributed to the chronic
mild memory loss of our patient. On the other hand,
subtle cardiac dysfunction (as quantified by cardiac
output) is believed also to be related to CNS injury
[15]. Bradycardia, particularly, is historically known to
be correlated with vasovagal syncope but neurological
deterioration may also occur without severe
hypotension and collapse; a small cohort of severely
bradycardic elderly patients showed that pacemaker
implantation improved their mental deterioration [16].
Table 1 Daily variation of blood pressure, heart rate (HR), BUN, serum creatinine and potassium with urine output
(oliguria < 400 ml/d and anuria < 100 ml/d)
Blood pressure in mmHg
(systolic/diastolic)
HR BUN (mg/dL) Serum creatinine (mg/dL) Serum potassium (mmol/L) Urine output (ml/day)
Day 1 150/55 50 80 2.3 4.9 600 ml
Day 2 130/55 40 82 2.46 5.1 600 ml
Day 3 110/45 33 89 2.77 5.5 Anuria
Day 4 110/40 34 110 3.37 5.2 Oliguria
Day 5 100/30 32 128 4.01 5.5 Oliguria
Day 6 110/45 85 133 3.74 4.7 5200 ml
Day 7 110/50 82 104 2.44 4.2 4300 ml
Day 8 105/55 82 75 1.37 3.7 1800 ml
Day 9 130/60 84 66 1.58 4.4 1700 ml
Day 10 130/60 60 55 1.5 4.2 1600 ml
Day 11 140/60 60 55 1.66 4 1250 ml
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Finally, complete AV block has also been associated
with drug-resistant epilepsy [17, 18].
Conclusion
As a summary, acute lowering of CO secondary to
complete AV block can lead to renal and cerebral hypo-
perfusion. Physicians should be aware that ejection frac-
tion and cardiac output are not similar, with cardiac
output being more reflective of systemic blood flow.
Bradyarrhythmia is a cause of decreased cardiac output
and can lead to hemodynamic instability if superimposed
on pre-existing heart failure, even in well preserved
systolic blood pressure cases. This hemodynamic
instability may cause simultaneously oligoanuria and
obnubilation. We conclude that complete AV block is a
cause for -what we called- a Cardio-Renal-Cerebral
Syndrome. Both renal and cerebral injuries are reversible
after pacemaker implantation.
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